{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T20:05:51Z","timestamp":1771531551507,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.ejphar.2011.02.042","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T03:59:46Z","timestamp":1299556786000},"page":"79-84","source":"Crossref","is-referenced-by-count":19,"title":["Disease-modifying effect of ASP3258, a novel phosphodiesterase type 4 inhibitor, on subchronic cigarette smoke exposure-induced lung injury in guinea pigs"],"prefix":"10.1016","volume":"659","author":[{"given":"Satoshi","family":"Kubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.02.042_bb0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-3565(24)29524-0","article-title":"Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs","volume":"297","author":"Aoki","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1183\/09031936.03.00040703","article-title":"Chronic obstructive pulmonary disease: molecular and cellular mechanisms","volume":"22","author":"Barnes","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1378\/chest.129.1.151","article-title":"Reduced histone deacetylase in COPD: clinical implications","volume":"129","author":"Barnes","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2011.02.042_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s000110300020","article-title":"The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?","volume":"52","author":"Belvisi","year":"2003","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1164\/rccm.200610-1563OC","article-title":"Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease","volume":"176","author":"Calverley","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrd3276","article-title":"Roflumilast","volume":"9","author":"Fabbri","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0035","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1164\/ajrccm.156.1.9612018","article-title":"Matrix metalloproteinase expression and production by alveolar macrophages in emphysema","volume":"156","author":"Finlay","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0040","doi-asserted-by":"crossref","first-page":"L1149","DOI":"10.1152\/ajplung.00481.2007","article-title":"Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin","volume":"294","author":"Foronjy","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/00003495-200059020-00004","article-title":"Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?","volume":"59","author":"Giembycz","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2011.02.042_bb0050","first-page":"30","article-title":"Anomalies in the endocrine axes of the guinea pig: relevance to human physiology and disease","volume":"17","author":"Keightley","year":"1996","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0055","unstructured":"Kobayashi, M., Kubo, S., Iwata, M., Ohtsu, Y., Takahashi, K., Shimizu, Y., in press. ASP3258, an orally active potent phosphodiesterase 4 inhibitor with low emetic activity. Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0060","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1183\/09031936.05.00042405","article-title":"Cytokine and chemokine expression in cigarette smoke-induced lung injury in guinea pigs","volume":"26","author":"Kubo","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0065","first-page":"395","article-title":"Effects of prednisolone, salbutamol and theophylline on bronchial hyperreactivity and leucocyte chemokinesis in guinea pigs","volume":"17","author":"Llupi\u00e1","year":"1991","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0070","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1164\/rccm.200411-1549OC","article-title":"Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke","volume":"172","author":"Martorana","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0075","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary","volume":"163","author":"Pauwels","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1378\/chest.129.1.56","article-title":"Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4","volume":"129","author":"Rennard","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2011.02.042_bb0085","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1165\/ajrcmb.26.5.4685","article-title":"Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease","volume":"26","author":"Russell","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0090","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1164\/ajrccm.163.6.2009116","article-title":"Cellular and structural bases of chronic obstructive pulmonary disease","volume":"163","author":"Saetta","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.02.042_bb0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0162-3109(00)00185-5","article-title":"Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors","volume":"47","author":"Souness","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ejphar.2011.02.042_bb0100","doi-asserted-by":"crossref","first-page":"188S","DOI":"10.1378\/chest.121.5_suppl.188S","article-title":"A model of tobacco smoke-induced airflow obstruction in the guinea pig","volume":"121","author":"Wright","year":"2002","journal-title":"Chest"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911002470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911002470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T18:52:57Z","timestamp":1741027977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911002470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0014299911002470"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.02.042","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}